Investor Contacts

Investors & Media

Investor Relations & Media Contact:

Kelly Boothe, PhD
Sr. Director, Corporate Communications & Investor Relations

(512) 399-5458
investors@aeglea.com
media@aeglea.com

Investor Contact

investors@aeglea.com
(512) 942-2935

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Aeglea BioTherapeutics Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Aeglea BioTherapeutics Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options *

News
Events & Presentations
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote

Unsubscribe

Email Alert Sign Up Confirmation

Company

About
Leadership
Partnering
Contact

Focus

Enzyme Therapeutics
Rare Metabolic Disease
Publications

Programs

Pipeline
Pegzilarginase
AGLE-177
Research Programs
Clinical Trials

Careers

Job
Openings
Life at Aeglea

Investors & Media

Company Overview
Press Releases
Events & Presentations
Stock Information
Financials & Filings
Corporate Governance
Resources